NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma
出版年份 2020 全文链接
标题
NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma
作者
关键词
Diffuse large B cell lymphoma, NLRP3, Interleukin-18, Immune checkpoints, Immunosuppression
出版物
CANCER LETTERS
Volume 497, Issue -, Pages 178-189
出版商
Elsevier BV
发表日期
2020-10-20
DOI
10.1016/j.canlet.2020.10.024
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy
- (2020) Balamayoora Theivanthiran et al. JOURNAL OF CLINICAL INVESTIGATION
- CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model
- (2020) Suet Ling Felce et al. Frontiers in Oncology
- Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression
- (2020) Smriti Gurung et al. BIOMATERIALS
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interleukin-18 in Health and Disease
- (2019) Koubun Yasuda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanisms Controlling PD-L1 Expression in Cancer
- (2019) Jong-Ho Cha et al. MOLECULAR CELL
- Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells
- (2018) Varun Sasidharan Nair et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma
- (2018) Li Li et al. BLOOD
- Role of the NLRP3 inflammasome in cancer
- (2018) Maryam Moossavi et al. Molecular Cancer
- Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases
- (2017) Si Ming Man et al. IMMUNOLOGICAL REVIEWS
- NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
- (2017) Donnele Daley et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
- (2017) V Atsaves et al. LEUKEMIA
- Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
- (2017) Y Liu et al. ONCOGENE
- The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines
- (2017) Toshifumi Doi et al. ONCOLOGY REPORTS
- NLRP3 inflammasome activation plays a carcinogenic role through effector cytokine IL-18 in lymphoma
- (2017) Xia Zhao et al. Oncotarget
- Inflammasomes and Cancer
- (2017) Rajendra Karki et al. Cancer Immunology Research
- T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells
- (2016) I. Azzaoui et al. BLOOD
- Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab
- (2016) M. Sade-Feldman et al. CLINICAL CANCER RESEARCH
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
- (2015) J. Kiyasu et al. BLOOD
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Regulatory T cells in cancer immunotherapy
- (2014) Hiroyoshi Nishikawa et al. CURRENT OPINION IN IMMUNOLOGY
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- IFN-γ-Stimulated Neutrophils Suppress Lymphocyte Proliferation through Expression of PD-L1
- (2013) Stan de Kleijn et al. PLoS One
- Inflammasomes in carcinogenesis and anticancer immune responses
- (2012) Laurence Zitvogel et al. NATURE IMMUNOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
- (2010) Christian Gisselbrecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma
- (2009) Adi Broyde et al. AMERICAN JOURNAL OF HEMATOLOGY
- Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice
- (2008) Shuiping Tu et al. CANCER CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More